Alvine Pharmaceuticals

Alvine Pharmaceuticals, Inc. is a privately held biopharmaceutical company focused on developing and commercializing treatments for autoimmune/gastrointestinal diseases. Alvine's lead product candidate, ALV003, is a combination of proteases designed to digest gluten. It is being developed for the treatment of patients with celiac disease.